Bagatell R, Whitesell L: Altered Hsp90 function in cancer: a unique therapeutic opportunity. Mol Cancer Ther. 2004, 3 (8): 1021-1030.
CAS
PubMed
Google Scholar
Isaacs JS, Xu W, Neckers L: Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer cell. 2003, 3 (3): 213-217. 10.1016/S1535-6108(03)00029-1.
Article
CAS
PubMed
Google Scholar
Nollen EA, Morimoto RI: Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci. 2002, 115 (Pt 14): 2809-2816.
CAS
PubMed
Google Scholar
Zhang H, Burrows F: Targeting multiple signal transduction pathways through inhibition of Hsp90. J Mol Med. 2004, 82 (8): 488-499. 10.1007/s00109-004-0549-9.
Article
CAS
PubMed
Google Scholar
Gooljarsingh LT, Fernandes C, Yan K, Zhang H, Grooms M, Johanson K, Sinnamon RH, Kirkpatrick RB, Kerrigan J, Lewis T, et al: A biochemical rationale for the anticancer effects of Hsp90 inhibitors: slow, tight binding inhibition by geldanamycin and its analogues. Proc Natl Acad Sci USA. 2006, 103 (20): 7625-7630. 10.1073/pnas.0602650103.
Article
CAS
PubMed
PubMed Central
Google Scholar
Neckers L, Ivy SP: Heat shock protein 90. Curr Opin Oncol. 2003, 15 (6): 419-424. 10.1097/00001622-200311000-00003.
Article
CAS
PubMed
Google Scholar
Taldone T, Gozman A, Maharaj R, Chiosis G: Targeting Hsp90: small-molecule inhibitors and their clinical development. Curr Opin Pharmacol. 2008, 8 (4): 370-374. 10.1016/j.coph.2008.06.015.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moser C, Lang SA, Kainz S, Gaumann A, Fichtner-Feigl S, Koehl GE, Schlitt HJ, Geissler EK, Stoeltzing O: Blocking heat shock protein-90 inhibits the invasive properties and hepatic growth of human colon cancer cells and improves the efficacy of oxaliplatin in p53-deficient colon cancer tumors in vivo. Mol Cancer Ther. 2007, 6 (11): 2868-2878. 10.1158/1535-7163.MCT-07-0410.
Article
CAS
PubMed
Google Scholar
Powers MV, Clarke PA, Workman P: Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer cell. 2008, 14 (3): 250-262. 10.1016/j.ccr.2008.08.002.
Article
CAS
PubMed
Google Scholar
Powers MV, Clarke PA, Workman P: Death by chaperone: HSP90, HSP70 or both?. Cell Cycle. 2009, 8 (4): 518-526. 10.4161/cc.8.4.7583.
Article
CAS
PubMed
Google Scholar
Ameri K, Hammond EM, Culmsee C, Raida M, Katschinski DM, Wenger RH, Wagner E, Davis RJ, Hai T, Denko N, et al: Induction of activating transcription factor 3 by anoxia is independent of p53 and the hypoxic HIF signalling pathway. Oncogene. 2007, 26 (2): 284-289. 10.1038/sj.onc.1209781.
Article
CAS
PubMed
Google Scholar
Lu D, Chen J, Hai T: The regulation of ATF3 gene expression by mitogen-activated protein kinases. Biochem J. 2007, 401 (2): 559-567. 10.1042/BJ20061081.
Article
CAS
PubMed
Google Scholar
Lu D, Wolfgang CD, Hai T: Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis. J Biol Chem. 2006, 281 (15): 10473-10481. 10.1074/jbc.M509278200.
Article
CAS
PubMed
Google Scholar
Bottone FG, Moon Y, Kim JS, Alston-Mills B, Ishibashi M, Eling TE: The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3). Mol Cancer Ther. 2005, 4 (5): 693-703. 10.1158/1535-7163.MCT-04-0337.
Article
CAS
PubMed
Google Scholar
Yin X, Dewille JW, Hai T: A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene. 2008, 27 (15): 2118-2127. 10.1038/sj.onc.1210861.
Article
CAS
PubMed
Google Scholar
Wang A, Arantes S, Conti C, McArthur M, Aldaz CM, MacLeod MC: Epidermal hyperplasia and oral carcinoma in mice overexpressing the transcription factor ATF3 in basal epithelial cells. Mol Carcinog. 2007, 46 (6): 476-487. 10.1002/mc.20298.
Article
CAS
PubMed
Google Scholar
Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, et al: The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res. 2006, 66 (24): 11983-11990. 10.1158/0008-5472.CAN-06-0943.
Article
CAS
PubMed
Google Scholar
Ishiguro T, Nagawa H: ATF3 gene regulates cell form and migration potential of HT29 colon cancer cells. Oncol Res. 2001, 12 (8): 343-346.
CAS
PubMed
Google Scholar
Ishiguro T, Nagawa H, Naito M, Tsuruo T: Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells. Jpn J Cancer Res. 2000, 91 (8): 833-836.
Article
CAS
PubMed
Google Scholar
Lang SA, Moser C, Gaumann A, Klein D, Glockzin G, Popp FC, Dahlke MH, Piso P, Schlitt HJ, Geissler EK, et al: Targeting heat shock protein 90 in pancreatic cancer impairs insulin-like growth factor-I receptor signaling, disrupts an interleukin-6/signal-transducer and activator of transcription 3/hypoxia-inducible factor-1alpha autocrine loop, and reduces orthotopic tumor growth. Clin Cancer Res. 2007, 13 (21): 6459-6468. 10.1158/1078-0432.CCR-07-1104.
Article
CAS
PubMed
Google Scholar
Bauer TW, Fan F, Liu W, Johnson M, Parikh NU, Parry GC, Callahan J, Mazar AP, Gallick GE, Ellis LM: Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor. Ann Surg. 2005, 241 (5): 748-756. 10.1097/01.sla.0000160699.59061.92. discussion 756-748
Article
PubMed
PubMed Central
Google Scholar
Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Wey JS, Parikh AA, Fan F, Reinmuth N, Kawaguchi M, Bucana CD, et al: Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors. Cancer Res. 2003, 63 (12): 3370-3377.
CAS
PubMed
Google Scholar
Stoeltzing O, Ahmad SA, Liu W, McCarty MF, Parikh AA, Fan F, Reinmuth N, Bucana CD, Ellis LM: Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis. Br J Cancer. 2002, 87 (10): 1182-1187. 10.1038/sj.bjc.6600598.
Article
CAS
PubMed
PubMed Central
Google Scholar
Stoeltzing O, Liu W, Reinmuth N, Fan F, Parikh AA, Bucana CD, Evans DB, Semenza GL, Ellis LM: Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human pancreatic cancer. The American journal of pathology. 2003, 163 (3): 1001-1011.
Article
CAS
PubMed
PubMed Central
Google Scholar
Dietmaier W, Gansbauer S, Beyser K, Renke B, Hartmann A, Rummele P, Jauch KW, Hofstadter F, Ruschoff J: Microsatellite instability in tumor and nonneoplastic colorectal cells from hereditary non-polyposis colorectal cancer and sporadic high microsatellite-instable tumor patients. Pathobiology. 2000, 68 (4-5): 227-231. 10.1159/000055928.
Article
CAS
PubMed
Google Scholar
Buganim Y, Kalo E, Brosh R, Besserglick H, Nachmany I, Rais Y, Stambolsky P, Tang X, Milyavsky M, Shats I, et al: Mutant p53 protects cells from 12-O-tetradecanoylphorbol-13-acetate-induced death by attenuating activating transcription factor 3 induction. Cancer Res. 2006, 66 (22): 10750-10759. 10.1158/0008-5472.CAN-06-0916.
Article
CAS
PubMed
Google Scholar
Hartman MG, Lu D, Kim ML, Kociba GJ, Shukri T, Buteau J, Wang X, Frankel WL, Guttridge D, Prentki M, et al: Role for activating transcription factor 3 in stress-induced beta-cell apoptosis. Mol Cell Biol. 2004, 24 (13): 5721-5732. 10.1128/MCB.24.13.5721-5732.2004.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hua B, Tamamori-Adachi M, Luo Y, Tamura K, Morioka M, Fukuda M, Tanaka Y, Kitajima S: A splice variant of stress response gene ATF3 counteracts NF-kappaB-dependent anti-apoptosis through inhibiting recruitment of CREB-binding protein/p300 coactivator. J Biol Chem. 2006, 281 (3): 1620-1629. 10.1074/jbc.M508471200.
Article
CAS
PubMed
Google Scholar
Mashima T, Udagawa S, Tsuruo T: Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis. J Cell Physiol. 2001, 188 (3): 352-358. 10.1002/jcp.1130.
Article
CAS
PubMed
Google Scholar
Oh YK, Lee HJ, Jeong MH, Rhee M, Mo JW, Song EH, Lim JY, Choi KH, Jo I, Park SI, et al: Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells. Mol Cancer Res. 2008, 6 (7): 1232-1249. 10.1158/1541-7786.MCR-07-0297.
Article
CAS
PubMed
PubMed Central
Google Scholar